Sequent Scientific Limited — Board Meeting, 11-02-2025: Outcome of Board Meeting

The Board of Directors has approved the unaudited consolidated financial results for the quarter and nine months ended December 31, 2024. Key figures include revenue from operations of ₹39,081.00 million and a net profit after tax of ₹648.00 million. Notably, total income stood at ₹39,665.00 million, while total expenses amounted to ₹38,824.00 million, resulting in a profit before tax of ₹841.00 million. The company showcased a strategic focus on operational restructuring, reflecting enhanced resilience against market fluctuations. Investors should monitor the positive trajectory in financial performance alongside ongoing operational improvements.